Development of a web-based application and multicountry analysis framework for assessing interdicted infections and cost-utility of screening donated blood for HIV, HCV and HBV.
Identifieur interne : 000087 ( Main/Exploration ); précédent : 000086; suivant : 000088Development of a web-based application and multicountry analysis framework for assessing interdicted infections and cost-utility of screening donated blood for HIV, HCV and HBV.
Auteurs : B. Custer [États-Unis] ; M P Janssen [Pays-Bas] ; G. Hubben [Allemagne] ; M. Vermeulen [Afrique du Sud] ; M. Van Hulst [Pays-Bas]Source :
- Vox sanguinis [ 1423-0410 ] ; 2017.
Abstract
Most countries test donations for HIV, HCV and HBV using serology with or without nucleic acid testing (NAT). Cost-utility analyses provide information on the relative value of different screening options. The aim of this project was to develop an open access risk assessment and cost-utility analysis web-tool for assessing HIV, HCV and HBV screening options (http://www.isbtweb.org/working-parties/transfusion-transmitted-infectious-diseases/). An analysis for six countries (Brazil, Ghana, the Netherlands, South Africa, Thailand and USA) was conducted.
DOI: 10.1111/vox.12538
PubMed: 28597489
Affiliations:
- Afrique du Sud, Allemagne, Pays-Bas, États-Unis
- Berlin, Californie, Groningue (province), Utrecht (province)
- Berlin, Groningue, Utrecht
- Université de Groningue
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000508
- to stream PubMed, to step Curation: 000508
- to stream PubMed, to step Checkpoint: 000508
- to stream Ncbi, to step Merge: 000B41
- to stream Ncbi, to step Curation: 000B41
- to stream Ncbi, to step Checkpoint: 000B41
- to stream Main, to step Merge: 000087
- to stream Main, to step Curation: 000087
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Development of a web-based application and multicountry analysis framework for assessing interdicted infections and cost-utility of screening donated blood for HIV, HCV and HBV.</title>
<author><name sortKey="Custer, B" sort="Custer, B" uniqKey="Custer B" first="B" last="Custer">B. Custer</name>
<affiliation wicri:level="2"><nlm:affiliation>Blood Systems Research Institute, San Francisco, CA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Blood Systems Research Institute, San Francisco, CA</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Janssen, M P" sort="Janssen, M P" uniqKey="Janssen M" first="M P" last="Janssen">M P Janssen</name>
<affiliation wicri:level="3"><nlm:affiliation>Julius Center for Health Sciences and Primary Care, UMC Utrecht, Utrecht, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Julius Center for Health Sciences and Primary Care, UMC Utrecht, Utrecht</wicri:regionArea>
<placeName><settlement type="city">Utrecht</settlement>
<region nuts="2" type="province">Utrecht (province)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Hubben, G" sort="Hubben, G" uniqKey="Hubben G" first="G" last="Hubben">G. Hubben</name>
<affiliation wicri:level="3"><nlm:affiliation>BaseCase, Berlin, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>BaseCase, Berlin</wicri:regionArea>
<placeName><region type="land" nuts="3">Berlin</region>
<settlement type="city">Berlin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Vermeulen, M" sort="Vermeulen, M" uniqKey="Vermeulen M" first="M" last="Vermeulen">M. Vermeulen</name>
<affiliation wicri:level="1"><nlm:affiliation>South African National Blood Service, Johannesburg, South Africa.</nlm:affiliation>
<country xml:lang="fr">Afrique du Sud</country>
<wicri:regionArea>South African National Blood Service, Johannesburg</wicri:regionArea>
<wicri:noRegion>Johannesburg</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Van Hulst, M" sort="Van Hulst, M" uniqKey="Van Hulst M" first="M" last="Van Hulst">M. Van Hulst</name>
<affiliation wicri:level="4"><nlm:affiliation>Department of PharmacoTherapy, Epidemiology & Economics, University of Groningen, Groningen, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of PharmacoTherapy, Epidemiology & Economics, University of Groningen, Groningen</wicri:regionArea>
<placeName><settlement type="city">Groningue</settlement>
<region nuts="2" type="province">Groningue (province)</region>
</placeName>
<orgName type="university">Université de Groningue</orgName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:28597489</idno>
<idno type="pmid">28597489</idno>
<idno type="doi">10.1111/vox.12538</idno>
<idno type="wicri:Area/PubMed/Corpus">000508</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000508</idno>
<idno type="wicri:Area/PubMed/Curation">000508</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000508</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000508</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000508</idno>
<idno type="wicri:Area/Ncbi/Merge">000B41</idno>
<idno type="wicri:Area/Ncbi/Curation">000B41</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000B41</idno>
<idno type="wicri:Area/Main/Merge">000087</idno>
<idno type="wicri:Area/Main/Curation">000087</idno>
<idno type="wicri:Area/Main/Exploration">000087</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Development of a web-based application and multicountry analysis framework for assessing interdicted infections and cost-utility of screening donated blood for HIV, HCV and HBV.</title>
<author><name sortKey="Custer, B" sort="Custer, B" uniqKey="Custer B" first="B" last="Custer">B. Custer</name>
<affiliation wicri:level="2"><nlm:affiliation>Blood Systems Research Institute, San Francisco, CA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Blood Systems Research Institute, San Francisco, CA</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Janssen, M P" sort="Janssen, M P" uniqKey="Janssen M" first="M P" last="Janssen">M P Janssen</name>
<affiliation wicri:level="3"><nlm:affiliation>Julius Center for Health Sciences and Primary Care, UMC Utrecht, Utrecht, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Julius Center for Health Sciences and Primary Care, UMC Utrecht, Utrecht</wicri:regionArea>
<placeName><settlement type="city">Utrecht</settlement>
<region nuts="2" type="province">Utrecht (province)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Hubben, G" sort="Hubben, G" uniqKey="Hubben G" first="G" last="Hubben">G. Hubben</name>
<affiliation wicri:level="3"><nlm:affiliation>BaseCase, Berlin, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>BaseCase, Berlin</wicri:regionArea>
<placeName><region type="land" nuts="3">Berlin</region>
<settlement type="city">Berlin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Vermeulen, M" sort="Vermeulen, M" uniqKey="Vermeulen M" first="M" last="Vermeulen">M. Vermeulen</name>
<affiliation wicri:level="1"><nlm:affiliation>South African National Blood Service, Johannesburg, South Africa.</nlm:affiliation>
<country xml:lang="fr">Afrique du Sud</country>
<wicri:regionArea>South African National Blood Service, Johannesburg</wicri:regionArea>
<wicri:noRegion>Johannesburg</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Van Hulst, M" sort="Van Hulst, M" uniqKey="Van Hulst M" first="M" last="Van Hulst">M. Van Hulst</name>
<affiliation wicri:level="4"><nlm:affiliation>Department of PharmacoTherapy, Epidemiology & Economics, University of Groningen, Groningen, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of PharmacoTherapy, Epidemiology & Economics, University of Groningen, Groningen</wicri:regionArea>
<placeName><settlement type="city">Groningue</settlement>
<region nuts="2" type="province">Groningue (province)</region>
</placeName>
<orgName type="university">Université de Groningue</orgName>
</affiliation>
</author>
</analytic>
<series><title level="j">Vox sanguinis</title>
<idno type="eISSN">1423-0410</idno>
<imprint><date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Most countries test donations for HIV, HCV and HBV using serology with or without nucleic acid testing (NAT). Cost-utility analyses provide information on the relative value of different screening options. The aim of this project was to develop an open access risk assessment and cost-utility analysis web-tool for assessing HIV, HCV and HBV screening options (http://www.isbtweb.org/working-parties/transfusion-transmitted-infectious-diseases/). An analysis for six countries (Brazil, Ghana, the Netherlands, South Africa, Thailand and USA) was conducted.</div>
</front>
</TEI>
<affiliations><list><country><li>Afrique du Sud</li>
<li>Allemagne</li>
<li>Pays-Bas</li>
<li>États-Unis</li>
</country>
<region><li>Berlin</li>
<li>Californie</li>
<li>Groningue (province)</li>
<li>Utrecht (province)</li>
</region>
<settlement><li>Berlin</li>
<li>Groningue</li>
<li>Utrecht</li>
</settlement>
<orgName><li>Université de Groningue</li>
</orgName>
</list>
<tree><country name="États-Unis"><region name="Californie"><name sortKey="Custer, B" sort="Custer, B" uniqKey="Custer B" first="B" last="Custer">B. Custer</name>
</region>
</country>
<country name="Pays-Bas"><region name="Utrecht (province)"><name sortKey="Janssen, M P" sort="Janssen, M P" uniqKey="Janssen M" first="M P" last="Janssen">M P Janssen</name>
</region>
<name sortKey="Van Hulst, M" sort="Van Hulst, M" uniqKey="Van Hulst M" first="M" last="Van Hulst">M. Van Hulst</name>
</country>
<country name="Allemagne"><region name="Berlin"><name sortKey="Hubben, G" sort="Hubben, G" uniqKey="Hubben G" first="G" last="Hubben">G. Hubben</name>
</region>
</country>
<country name="Afrique du Sud"><noRegion><name sortKey="Vermeulen, M" sort="Vermeulen, M" uniqKey="Vermeulen M" first="M" last="Vermeulen">M. Vermeulen</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000087 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000087 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= SidaGhanaV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:28597489 |texte= Development of a web-based application and multicountry analysis framework for assessing interdicted infections and cost-utility of screening donated blood for HIV, HCV and HBV. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:28597489" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a SidaGhanaV1
This area was generated with Dilib version V0.6.31. |